Sign in
4

Changes in Ownership

Rani Therapeutics Holdings, Inc. Filed Acc 0000950170-23-068442

Chief Executive Officer bought 5,000 shares at $2.57 ($12,850)

From the SEC's structured data for this filing

Trades in this filing

Imran Talat · Chief Executive Officer

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2023-12-04 Purchase : show line 1 in the form +5,000 $2.57 $12,850 474,455 D
Open-market purchases · 5,000 sh · avg $2.57 · $12,850
Loading xslF345X05/ownership.xml…